valproic acid has been researched along with belinostat in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Forgione, M; Hailu, GS; Mai, A; Robaa, D; Rotili, D; Sippl, W | 1 |
| Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bruserud, Ø; Corbascio, M; Eide, GE; Gjertsen, BT; Hatfield, K; Kalland, KH; Ryningen, A; Stapnes, C; Øyan, AM | 1 |
| Collins, L; Dejligbjerg, M; Grauslund, M; Jeffers, M; Jensen, PB; Lichenstein, H; Litman, T; Qian, X; Sehested, M | 1 |
| Figg, WD; Goey, AK; Peer, CJ; Sissung, TM | 1 |
2 review(s) available for valproic acid and belinostat
| Article | Year |
|---|---|
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
Topics: Animals; Antiparasitic Agents; Drug Repositioning; Helminth Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leishmania; Plasmodium; Protozoan Proteins; Schistosoma; Toxoplasma; Trypanosoma | 2017 |
Pharmacogenomics and histone deacetylase inhibitors.
Topics: Depsipeptides; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Panobinostat; Pharmacogenetics; Sulfonamides; Valproic Acid; Vorinostat | 2016 |
4 other study(ies) available for valproic acid and belinostat
| Article | Year |
|---|---|
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors.
Topics: Adult; Aged; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Profiling; Hematopoietic Stem Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Male; Middle Aged; Stromal Cells; Sulfonamides; Valproic Acid | 2007 |
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Topics: Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; HeLa Cells; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Protein Isoforms; Repressor Proteins; Sulfonamides; Transcription, Genetic; Valproic Acid | 2008 |